518 related articles for article (PubMed ID: 25205742)
1. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
2. [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids].
Riccardi C
Ann Ig; 2010; 22(1 Suppl 1):53-9. PubMed ID: 20701225
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action.
Ayroldi E; Riccardi C
FASEB J; 2009 Nov; 23(11):3649-58. PubMed ID: 19567371
[TBL] [Abstract][Full Text] [Related]
4. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor polymorphism affects transrepression but not transactivation.
van den Akker EL; Russcher H; van Rossum EF; Brinkmann AO; de Jong FH; Hokken A; Pols HA; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2006 Jul; 91(7):2800-3. PubMed ID: 16684836
[TBL] [Abstract][Full Text] [Related]
6. DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells.
Hontelez S; Karthaus N; Looman MW; Ansems M; Adema GJ
J Immunol; 2013 Apr; 190(7):3172-9. PubMed ID: 23440419
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
8. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
9. A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?
Ayroldi E; Cannarile L; Delfino DV; Riccardi C
Cell Death Dis; 2018 May; 9(5):463. PubMed ID: 29695779
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
11. Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Flynn JK; Dankers W; Morand EF
Front Immunol; 2019; 10():1684. PubMed ID: 31379872
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.
Srinivasan M; Lahiri DK
Mol Neurobiol; 2017 Dec; 54(10):8063-8070. PubMed ID: 27889894
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis.
Sevilla LM; Pérez P
Front Immunol; 2019; 10():2220. PubMed ID: 31572404
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the side effects of glucocorticoids.
Schäcke H; Döcke WD; Asadullah K
Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of action of glucocorticoids].
Dejean C; Richard D
Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
19. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
20. Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation.
Cannarile L; Delfino DV; Adorisio S; Riccardi C; Ayroldi E
Front Immunol; 2019; 10():1823. PubMed ID: 31440237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
